Spatial heterogeneity in the TME, including CD8+ T cell exclusion from tumor cores and enrichment of immunosuppressive M2 macrophages or Tregs, is compounded by CAF-mediated stromal barriers (e.g., IL-6, VEGF), which physically and biochemically restrict T cell infiltration [66,67]. The gene discussed is VEGFA; the disease is neoplasm.